Tags

Type your tag names separated by a space and hit enter

Screening, diagnosis, and management of gestational diabetes mellitus.
Am Fam Physician 2015; 91(7):460-7AF

Abstract

Gestational diabetes mellitus (GDM) affects approximately 6% of pregnancies in the United States, and it is increasing in prevalence. Pregnant women without known diabetes mellitus should be screened for GDM after 24 weeks of gestation. Treatment of GDM results in a statistically significant decrease in the incidence of preeclampsia, shoulder dystocia, and macrosomia. Initial management includes glucose monitoring and lifestyle modifications. If glucose levels remain above target values, pharmacologic therapy with metformin, glyburide, or insulin should begin. Antenatal testing is customary for women requiring medications. Induction of labor should not occur before 39 weeks in women with GDM, unless glycemic control is poor or another indication for delivery is present. Unless otherwise indicated, scheduled cesarean delivery should be considered only in women with an estimated fetal weight greater than 4,500 g. Women with a history of GDM are at high risk of subsequently developing diabetes. These patients should be screened six to 12 weeks postpartum for persistently abnormal glucose metabolism, and should undergo screening for diabetes every three years thereafter.

Authors+Show Affiliations

Central City Community Health Center and the University of Utah, Salt Lake City, UT, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25884746

Citation

Garrison, Andrew. "Screening, Diagnosis, and Management of Gestational Diabetes Mellitus." American Family Physician, vol. 91, no. 7, 2015, pp. 460-7.
Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus. Am Fam Physician. 2015;91(7):460-7.
Garrison, A. (2015). Screening, diagnosis, and management of gestational diabetes mellitus. American Family Physician, 91(7), pp. 460-7.
Garrison A. Screening, Diagnosis, and Management of Gestational Diabetes Mellitus. Am Fam Physician. 2015 Apr 1;91(7):460-7. PubMed PMID: 25884746.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Screening, diagnosis, and management of gestational diabetes mellitus. A1 - Garrison,Andrew, PY - 2015/4/18/entrez PY - 2015/4/18/pubmed PY - 2016/5/27/medline SP - 460 EP - 7 JF - American family physician JO - Am Fam Physician VL - 91 IS - 7 N2 - Gestational diabetes mellitus (GDM) affects approximately 6% of pregnancies in the United States, and it is increasing in prevalence. Pregnant women without known diabetes mellitus should be screened for GDM after 24 weeks of gestation. Treatment of GDM results in a statistically significant decrease in the incidence of preeclampsia, shoulder dystocia, and macrosomia. Initial management includes glucose monitoring and lifestyle modifications. If glucose levels remain above target values, pharmacologic therapy with metformin, glyburide, or insulin should begin. Antenatal testing is customary for women requiring medications. Induction of labor should not occur before 39 weeks in women with GDM, unless glycemic control is poor or another indication for delivery is present. Unless otherwise indicated, scheduled cesarean delivery should be considered only in women with an estimated fetal weight greater than 4,500 g. Women with a history of GDM are at high risk of subsequently developing diabetes. These patients should be screened six to 12 weeks postpartum for persistently abnormal glucose metabolism, and should undergo screening for diabetes every three years thereafter. SN - 1532-0650 UR - https://www.unboundmedicine.com/medline/citation/25884746/full_citation L2 - http://www.aafp.org/link_out?pmid=25884746 DB - PRIME DP - Unbound Medicine ER -